What anti-tuberculosis (TB) medications are safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Anti-Tuberculosis Drugs During Pregnancy

Isoniazid, rifampin, and ethambutol are the first-line anti-tuberculosis drugs that are considered safe for use during pregnancy, while streptomycin should be avoided due to its risk of fetal ototoxicity. 1

First-Line Anti-TB Drugs in Pregnancy

Safe Options

  • Isoniazid (INH):

    • Considered safe during pregnancy 1, 2
    • Crosses the placenta but not associated with human fetal malformations 3
    • Should be administered with pyridoxine (vitamin B6) 25mg/day to prevent peripheral neuropathy 1
    • Requires monitoring of liver function tests due to risk of hepatotoxicity
  • Rifampin (RIF):

    • Crosses the placenta but has not been shown to have teratogenic effects 1
    • Safe to use during pregnancy 1
    • May reduce efficacy of oral contraceptives due to enzyme induction
  • Ethambutol (EMB):

    • Considered safe for use in pregnancy 1
    • No demonstrated teratogenic effects in humans 1, 4
    • Can be used without undue concern 5

Drugs to Use with Caution

  • Pyrazinamide (PZA):
    • WHO and IUATLD recommend routine use in pregnant women 1
    • Not routinely recommended in the United States due to insufficient safety data 1
    • Some public health jurisdictions in the US have used it without reported adverse events 1
    • If not included, treatment duration should be extended to 9 months

Drugs to Avoid

  • Streptomycin:

    • Should NOT be used during pregnancy 1
    • Documented harmful effects on human fetus - interferes with ear development 1
    • Can cause congenital deafness in approximately 17% of exposed babies 1
  • Other aminoglycosides (kanamycin, amikacin) and capreomycin:

    • Presumed to share streptomycin's ototoxic potential 1
    • Should be avoided during pregnancy

Treatment Regimens During Pregnancy

Recommended Initial Regimen

The initial treatment regimen for pregnant women with tuberculosis should consist of:

  • Isoniazid (INH)
  • Rifampin (RIF)
  • Ethambutol (EMB) 1

If pyrazinamide is not included, treatment should be extended to a minimum of 9 months 1.

Special Considerations

  1. Breastfeeding:

    • First-line agents (INH, RIF, EMB) pass into breast milk in small amounts but do not produce toxic effects in nursing infants 1
    • Breastfeeding should not be discouraged for women on first-line agents 1
    • Supplementary pyridoxine is recommended for both nursing mother and infant if the mother is taking INH 1
  2. Monitoring:

    • Regular liver function tests are essential, especially with INH
    • Monthly clinical evaluations for adverse effects
    • Patient education about potential side effects to decrease maternal morbidity 6
  3. Timing of Treatment:

    • Treatment should be started as soon as tuberculosis is diagnosed 6
    • Delaying treatment poses significant risks to both mother and fetus 3

Second-Line Drugs in Pregnancy

For drug-resistant TB, treatment options are more limited:

  • Fluoroquinolones:

    • Associated with arthropathies in young animals
    • Should be avoided if possible during pregnancy 1
    • Ciprofloxacin has the best safety profile among second-line drugs if needed for drug-resistant TB 3
  • Ethionamide:

    • Limited data, but one report described nonspecific teratogenic effects 1
    • Should be avoided when possible
  • Cycloserine:

    • Insufficient data to determine safety in pregnancy 1

Important Considerations

  1. Counseling: Women being treated for drug-resistant TB should receive counseling about the risks to the fetus due to the known and unknown risks of second-line agents 1

  2. Abortion: Routine therapeutic abortion is not medically indicated for pregnant women taking first-line anti-TB drugs 5

  3. Supervised Treatment: Adherence to treatment can be especially difficult during pregnancy due to fear of medication effects and pregnancy-related nausea. Directly observed therapy (DOT) is particularly helpful in encouraging adherence 3

  4. Treatment Timing: Treatment should not be delayed as untreated tuberculosis poses a significant threat to the mother, fetus, and family 3

By following these guidelines, tuberculosis during pregnancy can be effectively treated while minimizing risks to both mother and baby.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of tuberculosis during pregnancy.

The American review of respiratory disease, 1980

Research

The maternal and fetal effects of tuberculosis therapy.

Obstetrics and gynecology clinics of North America, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.